» Articles » PMID: 16083968

The Diverse Functions of CD1d-restricted NKT Cells and Their Potential for Immunotherapy

Overview
Journal Immunol Lett
Date 2005 Aug 9
PMID 16083968
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

CD1d-restricted NKT cells have been identified as an important component of the immune system that have the capacity both to augment beneficial host immunity and to prevent harmful autoimmunity. These cells have the ability to produce a wide variety of cytokines, including both proinflammatory and antiinflammatory cytokines that can have multiple different effects on the outcome of immune reactions. The discovery that these T cells are activated by specific recognition of glycolipids in the glycosylceramide family has led to new approaches to manipulate the pleiotropic functions of these cells. Here, we review the multiple activities that have been attributed to NKT cells in a variety of different disease models, and the current state of our understanding of the mechanisms that control the functional outcome of NKT cell activation.

Citing Articles

Patient-Derived Organoid Models for NKT Cell-Based Cancer Immunotherapy.

Palacios P, Flores I, Cereceda L, Otero F, Muller M, Brebi P Cancers (Basel). 2025; 17(3).

PMID: 39941775 PMC: 11815936. DOI: 10.3390/cancers17030406.


Modulation of Immune Responses to Influenza A Virus Vaccines by Natural Killer T Cells.

Driver J, de Carvalho Madrid D, Gu W, Artiaga B, Richt J Front Immunol. 2020; 11:2172.

PMID: 33193296 PMC: 7606973. DOI: 10.3389/fimmu.2020.02172.


Understanding the freezing responses of T cells and other subsets of human peripheral blood mononuclear cells using DSMO-free cryoprotectants.

Pi C, Hornberger K, Dosa P, Hubel A Cytotherapy. 2020; 22(5):291-300.

PMID: 32220549 PMC: 7682753. DOI: 10.1016/j.jcyt.2020.01.013.


Thermodynamic and Structural Behavior of α-Galactosylceramide and C6-Functionalized α-GalCer in 2D Layers at the Air-Liquid Interface.

Brezesinski G, Calow A, Pereira C, Seeberger P Chembiochem. 2019; 21(1-2):241-247.

PMID: 31544285 PMC: 7004034. DOI: 10.1002/cbic.201900491.


Tag7 (PGLYRP1) Can Induce an Emergence of the CD3+CD4+CD25+CD127+ Cells with Antitumor Activity.

Sharapova T, Romanova E, Sashchenko L, Yashin D J Immunol Res. 2018; 2018:4501273.

PMID: 29850628 PMC: 5925135. DOI: 10.1155/2018/4501273.